Consensus grows for widening use of menopausal hormone therapy
Early medically induced menopause may increase cardiovascular risks
Acetaminophen vs. ibuprofen: Which should you take?
Hip bursitis vs. arthritis: How to tell the difference
Fitness for longevity: Which type matters most?
Ministrokes linked to elevated risk of dementia
Continuous glucose monitors benefit people who don't need insulin
CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides
Marc B. Garnick, MD
Editor in Chief, Harvard Medical School Annual Report on Prostate Diseases; Editorial Advisory Board Member, Harvard Health Publishing
Dr. Marc B. Garnick is an internationally renowned expert in medical oncology and urologic cancer. A clinical professor of medicine at Harvard Medical School, he also maintains an active clinical practice at Beth Israel Deaconess Medical Center. He has dedicated his career to the development of new therapies for the treatment of prostate cancer.
Dr. Garnick is the Editor in Chief of HarvardProstateKnowledge.org and Harvard Medical School’s Annual Report on Prostate Diseases, both of which emerged from his keen interest in explaining issues of medical importance to patients and their families to help them make appropriate treatment choices.
Consensus grows for widening use of menopausal hormone therapy
Early medically induced menopause may increase cardiovascular risks
Acetaminophen vs. ibuprofen: Which should you take?
Hip bursitis vs. arthritis: How to tell the difference
Fitness for longevity: Which type matters most?
Ministrokes linked to elevated risk of dementia
Continuous glucose monitors benefit people who don't need insulin
CoQ10: Should you take this popular supplement if you're on a statin?
Microplastics: A hidden health threat?
Oat vs. dairy milk: Nutrition, benefits, and downsides